Mannose-binding lectin (MBL) insufficiency protects against the development of systemic inflammatory response after pediatric cardiac surgery

Immunobiology

Volumn 221, Issue 2, 2016, Pages 175-181

  Pągowska Klimek, Izabela ^a   Świerzko, Anna S ^b   Michalski, Mateusz ^b   Moll, Maciej ^a   Szala Poździej, Agnieszka ^b   Sokołowska, Anna ^b   Krajewski, Wojciech R ^a   Cedzyński, Maciej ^b  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^b INSTITUTE OF MEDICAL BIOLOGY   (Poland)

Author keywords

Cardiopulmonary bypass (CPB); Complement; Congenital heart disease; Mannan binding lectin; Mannose binding lectin (MBL); SIRS

Indexed keywords

MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 1; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 2; MANNOSE BINDING LECTIN; MANNOSE BINDING LECTIN 2; SERINE PROTEINASE; UNCLASSIFIED DRUG; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MASP1 PROTEIN, HUMAN; MASP2 PROTEIN, HUMAN; MBL2 PROTEIN, HUMAN;

ADOLESCENT; ARTICLE; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DEATH; FEMALE; FEVER; FORWARD HEART FAILURE; GENETIC ASSOCIATION; GENOTYPE; HEART SURGERY; HETEROZYGOTE; HUMAN; INCIDENCE; INFANT; INFECTION; KIDNEY FAILURE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MASP2 GENE; MBL2 GENE; MULTIPLE ORGAN FAILURE; PEDIATRIC SURGERY; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; PROTECTION; PROTEIN BLOOD LEVEL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ADVERSE EFFECTS; BLOOD; CARDIAC OUTPUT, LOW; CARDIOPULMONARY BYPASS; DEFICIENCY; GENE EXPRESSION; GENETICS; HEART OUTPUT; IMMUNE DEFICIENCY; IMMUNOLOGY; INBORN ERROR OF METABOLISM; METABOLISM; PATHOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; CARDIAC OUTPUT; CARDIAC OUTPUT, LOW; CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION; GENOTYPE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; MALE; MANNOSE-BINDING LECTIN; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; METABOLISM, INBORN ERRORS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROTECTIVE FACTORS; RISK FACTORS;

EID: 84989790804     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2015.09.010     Document Type: Article

References (41)

1. Algra, S.O., Driessen, M.M., Schadenberg, A.W., et al. Bedside prediction rule for infections after pediatric cardiac surgery. Intensive Care Med. 38:3 (2012), 474–481.
2. Bak-Romaniszyn, L., Szala, A., Sokolowska, A., et al. Mannan-binding lectin deficiency in pediatric patients with inflammatory bowel disease. Scand. J. Gastroenterol. 46 (2011), 1275–1278.
3. Bilgin, Y.M., Brand, A., Berger, S.P., Mannose-binding lectin is involved in multiple organ dysfunction syndrome after cardiac surgery: effects of blood transfusions. Transfusion 48:4 (2008), 601–608.
4. Cedzynski, M., Szemraj, J., Swierzko, A.S., et al. Mannan-binding lectin (MBL) insufficiency in children with recurrent infections of the respiratory system. Clin. Exp. Immunol. 136 (2004), 304–311.
5. Degn, S.E., Jensen, L., Hansen, A.G., et al. Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function. J. Immunol. 189:8 (2012), 3957–3969.
6. Dobo, J., Major, B., Kekesi, K.A., et al. Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP)-1. PLoS One, 6(5), 2011, e20036.
7. Eisen, D.P., Dean, M.M., Boermeester, M.A., et al. Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin. Infect. Dis. 47 (2008), 510–516.
8. Fidler, K.J., Wilson, P., Davies, J.C., Turner, M.W., Peters, M.J., Klein, N.J., Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin. Intensive Care Med. 30:7 (2004), 1438–1445.
9. Gaies, M.G., Gurney, J.G., Yen, A.H., et al. Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr. Crit. Care Med. 11:2 (2010), 234–238.
10. Garred, P., J Strøm, J., Quist, L., Taaning, E., Madsen, H.O., Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J. Infect. Dis. 188:9 (2003), 1394–1403.
11. Goldstein, B., Giroir, B., Randolph, A., et al. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr. Crit. Care Med. 6:1 (2005), 2–8.
12. Greco, G., Shi, W., Michler, R.E., Meltzer, D.O., et al. Costs associated with healthcare-associated infections in cardiac surgery. J. Am. Coll. Cardiol. 65:1 (2015), 15–23.
13. Haahr-Pedersen, S., Bjerre, M., Flyvbjerg, A., et al. Level of complement activity predict cardiac dysfunction after acute myocardial infarction treated with primary percutaneous coronary intervention. J. Invasive Cardiol. 21:1 (2009), 13–19.
14. Heja, D., Harmat, V., Fodor, K., et al. Monospecific inhibitors show that both mannan-binding lectin-associated serine protease-1 (MASP-1) and -2 are essential for lectin pathway activation and reveal structural plasticity of MASP-2. J. Biol. Chem. 287:24 (2012), 20290–20300.
15. Hoffman, T.M., Wernovsky, G., Atz, A.M., et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Am. Heart J. 143 (2002), 15–21.
16. Hou, Y.J., Lee, D.C., Ko, W., et al. Perioperative mannan-binding lectin (MBL) patterns in cardiac surgery may correlate with the clinical outcomes in MBL deficient patients. Ann. Thorac. Surg. 90:4 (2010), 1357–1358.
17. Keizer, M.P., Wouters, D., Schlapbach, L.J., Kuijpers, T.W., Restoration of MBL-deficiency: redefining the safety, efficacy and viability of MBL-substitution therapy. Mol. Immunol. 61:2 (2014), 174–184.
18. Kilpatrick, D.C., Mannan-binding lectin and its role in innate immunity. Transfus. Med. 12:6 (2002), 335–352.
19. Kozik, D.J., Tweddell, J.S., Characterizing the inflammatory response to cardiopulmonary bypass in children. Ann. Thorac. Surg. 81 (2006), S2347–S2354.
20. Lai, L.T., Lee, D.C., Ko, W., Shevde, K., Zhang, M., Deficiency of complement factor MBL in a patient required cardiac surgery after an acute myocardial infarction with underlining chronic lymphocytic leukemia. Int. J. Cardiol. 139 (2010), e24–e26.
21. Luo, J., Xu, F., Lu, G.J., Lin, H.C., Feng, Z.C., Low mannose-binding lectin (MBL) levels and MBL genetic polymorphisms associated with the risk of neonatal sepsis: an updated meta-analysis. Early Hum. Dev. 90:10 (2014), 557–564.
22. Madsen, H.O., Garred, P., Thiel, S., et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J. Immunol. 155 (1995), 3013–3020.
23. Marcheix, B., Carrier, M., Martel, C., Effect of pericardial blood processing on postoperative inflammation and the complement pathways. Ann. Thorac. Sur. 85 (2008), 530–535.
24. Neth, O., Jack, D.L., Johnson, M., Klein, N.J., Turner, M.W., Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus. J. Immunol. 169:8 (2002), 4430–4436.
25. Pągowska-Klimek, I., Cedzyński, M., Mannan-binding lectin in cardiovascular disease. Biomed. Res. Int., 2014, 616817.
26. Pesonen, E., Hallman, M., Sarna, S., et al. Mannose-binding lectin as a risk factor for acute coronary syndromes. Ann. Med. 41:8 (2009), 591–598.
27. Presanis, J., Hajela, K., Ambrus, G., Gal, P., Sim, R.B., Differential substrate and inhibitor profiles for human MASP-1 and MASP-2. Mol. Immunol. 40 (2004), 921–929.
28. Sallenbach, S., Thiel, S., Aebi, C., et al. Serum concentrations of lectin-pathway components in healthy neonates, children and adults: mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2). Pediatr. Allergy Immunol. 22 (2011), 424–430.
29. Saevarsdottir, S., Oskarsson, O., Aspelund, T., et al. Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk. J. Exp. Med. 201:1 (2005), 117–125.
30. Schoos, M.M., Munthe-Fog, L., Skjoedt, M.O., et al. Association between lectin pathway initiators, C-reactive protein and left ventricular remodeling in myocardial infarction—a magnetic resonance study. Mol. Immunol. 54:3–4 (2013), 408–414.
31. Schwaeble, W.J., Lynch, N.J., Clark, J.E., et al. Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 7523–7528.
32. Seghaye, M.C., The clinical implications of the systemic inflammatory reaction related to cardiac operations in children. Cardiol. Young 13 (2003), 228–239.
33. Siassi, M., Hohenberger, W., Riese, J., Mannan-binding lectin (MBL) serum levels and post-operative infections. Biochem. Soc. Trans. 31:Pt 4 (2003), 774–775.
34. Smith, P.K., Shernan, S.K., Chen, J.C., et al. Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials. J. Thorac. Cardiovasc. Sur. 142 (2011), 89–98.
35. Smithson, A., Perello, R., Aibar, J., et al. Genotypes coding for low serum levels of mannose-binding lectin are under represented among individuals suffering from noninfectious systemic inflammatory response syndrome. Clin. Vaccine Immunol. 17:3 (2010), 447–453.
36. Swierzko, A.S., Szala, A., Cedzynski, M., et al. Mannan-binding lectin genotypes and genotype phenotype relationships in a large cohort of Polish neonates. Hum. Immunol. 70:1 (2009), 68–72.
37. Swierzko, A.S., Szala, A., Sawicki, S., et al. Mannose-binding lectin (MBL) and MBL-associated serine protease-2 (MASP-2) in women with malignant and benign ovarian tumours. Cancer Immunol. Immunother. 11 (2014), 1129–1140.
38. Turner, M.W., Deficiency of mannan-binding protein—a new complement deficiency syndrome. Clin. Exp. Immunol. 186:Suppl. 1 (1991), 53–56.
39. Turner, M.W., Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol. Today 17:11 (1996), 532–540.
40. Vengen, I.T., Madsen, H.O., Garred, P., Platou, C., Vatten, L., Videm, V., Mannose-binding lectin deficiency is associated with myocardial infarction: the HUNT2 study in Norway. Ann. Med. 41 (2009), 591–598.
41. Wernovsky, G., Wypij, D., Jonas, R.A., et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 92 (1995), 2226–2235.